Skip to main content

Table 3 Hazard ratios of survival through the clinicopathological characteristics by multivariate analysis in recurrent ovarian cancer patients

From: CA-125–indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery

Characteristic Overall survival Progression free survival
HR 95% CI HR 95% CI
FIGO stage
 I 1.000 Reference 1.00 Reference
 II 1.04 0.44–2.44 1.08 0.68-1.73
 III 1.62 0.67–4.88 1.21 0.27-5.40
 IV 2.27 1.83–6.69 1.72 1.66-4.46
Grade 1.93 0.84–4.36 2.49 1.05-2.94
Primary CRS 1.06 0.58–2.86 1.65 1.08–2.86
Secondary CRS 1.41 1.01–2.10 1.77 1.14-2.74
Ascites 1.79 1.05–3.04 1.83 1.03-3.27
Relapse/Nadir CA-125 level 1.00 1.00–1.01 1.00 1.00-1.01
  1. Abbreviations: HR, hazard ratio; CI, confidence interval; FIGO, International Federation of Gynecology and Obstetrics; CRS, cytoreductive surgery.